z-logo
open-access-imgOpen Access
Autoimmune Markers in Diabetes
Author(s) -
William E. Winter,
Desmond Schatz
Publication year - 2010
Publication title -
clinical chemistry
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.705
H-Index - 218
eISSN - 1530-8561
pISSN - 0009-9147
DOI - 10.1373/clinchem.2010.148205
Subject(s) - autoantibody , islet , autoimmunity , type 1 diabetes , immunology , medicine , etiology , diabetes mellitus , autoimmune disease , pathogenesis , antibody , endocrinology
Type 1 diabetes (T1DM) results from cell-mediated autoimmune destruction of the β cells of the islets of Langerhans. Autoantibodies directed against the islets are useful clinical tools that allow the recognition and confirmation of β-cell autoimmunity.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom